M-230

N/A

Report date: 2024/04/25 11:58:34

Base Information

Drug NameM-230

Drug Alias NameRecombinant trivalent human IgG1 Fc multimerCSL-730 rFc MultimerCSL-730M-230SIF-3

ClassificationBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionImmunomodulatorsIgA Fc receptor modulators

TargetsIgA Fc receptor

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlandsUnited Kingdom

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCsl Behring

Active IndicationsN/A

Inactive IndicationsAutoimmune Diseases

ATC CodeN/A